[Twenty-four weeks therapy with peginterferon alfa-2a could be similar to 48 weeks therapy in patients with HBeAg positive chronic hepatitis B and good predictors of response: results of a pilot study] (Q83007564)
Jump to navigation
Jump to search
scientific article published on 01 December 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | [Twenty-four weeks therapy with peginterferon alfa-2a could be similar to 48 weeks therapy in patients with HBeAg positive chronic hepatitis B and good predictors of response: results of a pilot study] |
scientific article published on 01 December 2009 |
Statements
[Twenty-four weeks therapy with peginterferon alfa-2a could be similar to 48 weeks therapy in patients with HBeAg positive chronic hepatitis B and good predictors of response: results of a pilot study] (English)
Joaquín Solari
Omar Galdame
Lucrecia Rezzonico
Bernardo Frider
Alejandra Villamil
Paola Casciato
Juan Carlos Bandi
Analía Alessio
Adrían Gadano
1 December 2009